IBBR Publications

Found 64 results
Filters: Author is Muro, Silvia  [Clear All Filters]
2014
Rappaport J, Garnacho C, Muro S. Clathrin-Mediated Endocytosis Is Impaired in Type A-B Niemann-Pick Disease Model Cells and Can Be Restored by ICAM-1-Mediated Enzyme Replacement. Mol Pharm. 2014 .
Papademetriou I, Tsinas Z, Hsu J, Muro S. Combination-targeting to multiple endothelial cell adhesion molecules modulates binding, endocytosis, and in vivo biodistribution of drug nanocarriers and their therapeutic cargoes. J Control Release. 2014 ;188C:87-98.
Ghaffarian R, Muro S. Distinct Subcellular Trafficking Resulting from Monomeric vs Multimeric Targeting to Endothelial ICAM-1: Implications for Drug Delivery. Mol Pharm. 2014 .
Muro S. A DNA-Device that Mediates Selective Endosomal Escape and Intracellular Delivery of Drugs and Biologicals. Adv Funct Mater. 2014 ;24(19):2899-2906.
Hsu J, Bhowmick T, Burks SR, P Y Kao J, Muro S. Enhancing biodistribution of therapeutic enzymes in vivo by modulating surface coating and concentration of ICAM-1-targeted nanocarriers. J Biomed Nanotechnol. 2014 ;10(2):345-54.
Shapiro B, Kulkarni S, Nacev A, Muro S, Stepanov PY, Weinberg IN. Open challenges in magnetic drug targeting. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2014 .
Hsu J, Rappaport J, Muro S. Specific Binding, Uptake, and Transport of ICAM-1-Targeted Nanocarriers Across Endothelial and Subendothelial Cell Components of the Blood-Brain Barrier. Pharm Res. 2014 .
Hsu J, Hoenicka J, Muro S. Targeting, Endocytosis, and Lysosomal Delivery of Active Enzymes to Model Human Neurons by ICAM-1-Targeted Nanocarriers. Pharm Res. 2014 .